Navigation Links
MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial
Date:9/8/2010

MOUNTAIN VIEW, Calif., Sept. 8 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today reported results from a pharmacodynamics (PD) trial comparing the acute effects on pulmonary artery pressure of LEVADEX™, dihydroergotamine mesylate (DHE) administered intravenously (IV) and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.

LEVADEX was well tolerated and there were no drug-related serious adverse events reported. There were no clinically significant changes in any cardiovascular parameters measured in this trial. There were no mean increases in QT interval in the LEVADEX group. All pharmacokinetic results in this trial were consistent with those reported in previous LEVADEX trials."Intravenous DHE has been used safely for over 60 years, and we wanted to evaluate whether LEVADEX, with its novel administration through the lung, would have an effect on pulmonary artery pressure. We are pleased to report that LEVADEX did not have an effect on pulmonary artery pressure compared to placebo and was, in fact, less than that seen with IV DHE," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals.

Pulmonary artery pressure in the IV DHE group was higher than both the LEVADEX and placebo groups. In addition, even after a second dose of LEVADEX was administered two hours after the first dose, pulmonary artery pressure was not higher in the LEVADEX group than in the IV DHE group.  

The PD trial was a randomized, double blind, placebo controlled, three-way, crossover trial in 24 healthy adults and was designed to compare the acute e
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Isis Pharmaceuticals to Present at the Stifel Nicolaus 2010 Healthcare Conference
2. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
3. Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010
4. Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
7. Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
8. Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
9. Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
10. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
11. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... LAKES, N.J. , May 24, 2013  BD (Becton, ... global medical technology company, announced today that it will present ... Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET). ... be accessed from the BD corporate website at www.bd.com/investors ... 6, 2013.    About BD BD ...
(Date:5/24/2013)... May 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that Dr. Robert Grieve ... Jason Napolitano , executive vice president and chief ... Conference, which is being held May 30, 2013 in ... Hotel. The Company,s presentation is scheduled to ...
(Date:5/24/2013)... 24, 2013  Sinovac Biotech Ltd. (NASDAQ: ... products in China , announced ... of Sinovac, obtained the Certificate of Good Manufacturing ... China State and Food Administration (CFDA) for its ... and its Changping filing and packaging facility. The ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
... Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance ... Fractional Flow Reserve (FFR) technology can now integrate with the FFR modules of hemodynamic monitoring systems from ... ... , ...
... March 12 Delcath Systems, Inc. (Nasdaq: DCTH ), which is testing its proprietary treatment system for primary and metastatic cancers to the liver, today provided an update on recent corporate developments.   , ... , , ... ... Recent Highlights , ...
Cached Medicine Technology:Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems 2Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems 3Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems 4Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems 5Delcath Systems Provides Update on Corporate Developments 2Delcath Systems Provides Update on Corporate Developments 3Delcath Systems Provides Update on Corporate Developments 4Delcath Systems Provides Update on Corporate Developments 5Delcath Systems Provides Update on Corporate Developments 6Delcath Systems Provides Update on Corporate Developments 7Delcath Systems Provides Update on Corporate Developments 8Delcath Systems Provides Update on Corporate Developments 9Delcath Systems Provides Update on Corporate Developments 10Delcath Systems Provides Update on Corporate Developments 11Delcath Systems Provides Update on Corporate Developments 12
(Date:5/24/2013)... Lincoln, RI (PRWEB) May 24, 2013 With ... That’s why Amica Insurance is offering tips to ... The National Fire Protection Association (NFPA) reports that ... between 2006 and 2010. Charcoal or other solid-fueled grills, meanwhile, ... period. , As a result, Amica Insurance is sharing the ...
(Date:5/24/2013)... research suggests a link between sleep duration and ... additional hour someone with insomnia sleeps is associated ... of moderate or high risk of suicide, according ... "We were surprised by the strength of ... study author, Linden Oliver, clinical research coordinator for ...
(Date:5/24/2013)... JOLLA, Calif.) (PRWEB) May 24, 2013 ... to House Appropriators and the California congressional delegation, ... to restore sequestered industry user fees paid to ... and to ensure that future across-the-board cuts will ... part of the FY14 Agriculture, Rural Development and ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- Drugs commonly used ... side effects that can interfere with vision, according to ... analogues (PGAs), which are used to reduce eye pressure, ... and changes in eye color, the researchers said, suggesting ... for PGAs. Doctors should be conservative when ...
(Date:5/24/2013)... Let’s face it: very few are luckily gifted ... majority of people to be uncomfortable with the color of ... addiction or simply genetics, yellowish or stained teeth suppresses confidence ... , Herald Square Dental is proud to announce the ... White Max. , Teeth become discolored for a number ...
Breaking Medicine News(10 mins):Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2
... a study of pregnant women, those with pregnancy-induced high ... a peptide that raises blood pressure in the pieces ... at Wake Forest University Baptist Medical Center. The finding, ... how the disorder develops. , Preeclampsia, or high blood ...
... Raises Funds and Awareness for Chronic Kidney Disease ... The following release was,issued today by the ... WHO: Casino Night attracts a diverse group of ... philanthropic communities in the Greater,Washington, DC region. Special ...
... for UNICEF, EAGLE, Idaho, Feb. 8 ... among eleven chefs sharing their favorite,Idaho Potato recipes ... program. The goal of this unique program is ... the International Year of the Potato by,raising awareness ...
... Mobility, a,leading manufacturer of mobility products, and Amerityre ... tires and tire products, are,pleased to announce Amerityre,s ... on the Amigo Mobility SmartShopper. It is,estimated that ... tires per year., "We are very happy ...
... to encourage Americans to ... 8 , Who: "The Biggest Loser" Season three runner-up Mark Wylie ... Hoover, along with MSN Health & Fitness ... discuss "The Biggest Loser" Million Pound Match-Up sweepstakes, ...
... chat improves cross-language customer support and collaboration, ... today that,PetlinQ(TM), a web-based application used to transport ... physicians, has signed on,to use the new SpeakLike ... Internet chat translation service that,seamlessly integrates automated and ...
Cached Medicine News:Health News:New finding may help explain development of preeclampsia 2Health News:Idaho Potato Commission Launches 'Recipes for Relief' in Celebration of the International Year of the Potato 2Health News:Idaho Potato Commission Launches 'Recipes for Relief' in Celebration of the International Year of the Potato 3Health News:Idaho Potato Commission Launches 'Recipes for Relief' in Celebration of the International Year of the Potato 4Health News:Amigo Mobility Selects Amerityre as OEM Supplier 2Health News:Amigo Mobility Selects Amerityre as OEM Supplier 3Health News:Mark Wylie and Suzy Preston Hoover Bring 'The Biggest Loser' Million Pound Tour, Presented by MSN, to Dadeland Mall 2Health News:PetlinQ Signs Agreement With SpeakLike for Accurate, Real-Time Translation Chat 2
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Medicine Products: